In plants, the nucleocytoplasmic protein EDS1 (Enhanced disease susceptibility1) is an important regulator of innate immunity, coordinating host-cell defence and cell-death programs in response to pathogen attack. Arabidopsis thaliana EDS1 stabilizes and signals together with its partners PAD4 (Phytoalexin deficient4) and SAG101 (Senescence-associated gene101). Characterization of EDS1 molecular configurations in vitro and in vivo points to the formation of structurally and spatially distinct EDS1 homomeric dimers and EDS1 heteromeric complexes with either PAD4 or SAG101 as necessary components of the immune response. EDS1, PAD4 and SAG101 constitute a plant-specific protein family with a unique 'EP' (EDS1-PAD4-specific) domain at their C-termini and an N-terminal domain resembling enzymes with an /-hydrolase fold. Here, the expression, purification and crystallization of a functional EDS1 complex formed by EDS1 and SAG101 from Arabidopsis thaliana are reported. The crystals belonged to the orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a = 101.8, b = 115.9, c = 122.8 Å , and diffracted to 3.5 Å resolution.
Introduction
The plant innate immune system relies on tight regulation of defence and cell-death programs triggered in individual cells by an attacking pathogen. In the model plant Arabidopsis thaliana, EDS1 (Enhanced disease susceptibility1; Aarts et al., 1998; Falk et al., 1999) has emerged as a central immune regulator García & Parker, 2010) . Together with its sequence-related partners PAD4 (Phytoalexin deficient4) and SAG101 (Senescence-associated gene101), EDS1 controls low-level 'basal' immunity to virulent pathogens and a more acute resistance reaction involving programmed cell death mediated by certain intracellular nucleotidebinding leucine-rich repeat (NB-LRR) receptors that recognize specific pathogen effectors (Zhou et al., 1998; Jirage et al., 1999; Feys et al., 2001 Feys et al., , 2005 .
Arabidopsis EDS1 is a soluble nucleocytoplasmic protein that forms molecularly and spatially different complexes with PAD4 and SAG101 in vivo . Analysis of the molecular configurations of individual EDS1 complexes expressed in yeast or as recombinant proteins purified from Escherichia coli showed that EDS1 can form homomeric dimers and stabilize PAD4 and SAG101 in heteromeric associations (S. Rietz & J. Parker, unpublished results). The data indicate that EDS1 uses different structural determinants to interact with PAD4 or SAG101 in separate complexes that have different signalling activities. Whereas EDS1 dimers are mostly cytoplasmic in vivo, EDS1-PAD4 heteromeric complexes accumulate in the nucleus and cytoplasm and EDS1-SAG101 complexes are confined to nuclei . The presence of distinct EDS1 complexes in different cellular compartments suggests that dynamic interactions between EDS1 nuclear and cytoplasmic pools are important in defence signal relaying. Indeed, coordination between the EDS1 cytoplasmic and nuclear pools via the nuclear pore trafficking machinery is necessary for resistance to pathogens (Cheng et al., 2009; García et al., 2010) .
Based on primary-sequence analysis, the N-terminal domain of EDS1 has homology to proteins of the /-hydrolase fold family, including three residues that comprise a serine hydrolase Ser-Asp-His catalytic triad (Ollis et al., 1992) . EDS1 shares this overall homology and a unique C-terminal 'EP' (EDS1-PAD4-specific) domain with PAD4 and SAG101, although SAG101 lacks the canonical catalytic triad (He & Gan, 2002; Wiermer et al., 2005) . While low acyl esterase activity was found for SAG101 (He & Gan, 2002) , neither EDS1 nor PAD4 has been reported to possess serine esterase catalytic activity. However, EDS1 and PAD4 are needed to transduce reactive-oxygenspecies-derived signals leading to cell death in photooxidative stress and immune responses, suggesting the involvement of a redox component in EDS1 signal transduction (Mateo et al., 2004; Mü hlenbock et al., 2008; Straus et al., 2010) .
The combined genetic and molecular data position EDS1 as a central biotic stress signalling 'node' in plants, but a detailed biochemical mechanism for the coordination of multiple defence outputs by EDS1 remains elusive. To investigate the physicochemical nature of the associations and functional dynamics of EDS1, we undertook the purification of EDS1 complexes from E. coli for crystallization. Here, we report the expression, purification and crystallization of an A. thaliana EDS1-SAG101 heterodimer. Structure solution of this complex should provide crucial mechanistic insights into the pathways operating in plant innate immunity.
Materials and methods

Protein expression and purification
The EDS1 coding sequence (Falk et al., 1999) was amplified by PCR using oligonucleotides containing NdeI/XhoI restriction sites and was cloned into pET42a(+) (Invitrogen) without an additional tag. The SAG101 coding sequence was amplified as a BamHI/KpnI fragment and was cloned into pRSF-Duet (Invitrogen) as an N-terminal His-tag fusion. Both constructs were subsequently transformed separately into E. coli strain BL21 (DE3) Rosetta (Novagen). Expression of a 0.4 l culture in LB medium was induced at an OD of 0.8 with 0.2 mM IPTG and the cells were shaken at 180 rev min À1 overnight at 285 K. The cells were harvested by centrifugation and resuspended in buffer A (50 mM NaH 2 PO 4 , 100 mM NaCl, 20 mM imidazole, 1 mM DTT, 10% glycerol pH 8.0) with 1 mg ml À1 lysozyme and 10 mg ml
À1
DNase I. Cells expressing EDS1 and His-SAG101 were mixed at this stage to allow the binding of nontagged EDS1 to His-SAG101. After 30 min incubation on ice, the cells were sonicated for a total of 2 min (four cycles, 40% output). Cell debris was removed by centrifugation at 20 000g for 30 min at 277 K. The supernatant was filtered and loaded onto a 1 ml Ni-NTA Superflow column (Qiagen) preequilibrated with buffer A. After rigorous washing (ten column volumes) with buffer A, the complex was eluted in a buffer consisting of 50 mM NaH 2 PO 4 , 100 mM NaCl, 250 mM imidazole, 1 mM DTT, 10% glycerol pH 7.5. The eluate was concentrated to a volume of less than 1.5 ml, applied onto a HiLoad 16/60 Superdex 200 size-exclusion column (Amersham Pharmacia) and eluted in 40 mM imidazole, 50 mM NaCl, 1 mM DTT pH 7.4. The purity and stoichiometry of the complex were checked by SDS-PAGE analysis. Fractions containing pure complex were pooled and concentrated to 8-12 mg ml À1 using Amicon-15 ultrafiltration units (Millipore).
Crystallization
All crystallization experiments were performed at 293 K using the sitting-drop vapour-diffusion method. Initial screens were set up in 96-well plates (Art Robbins) using commercial sparse-matrix and grid screens from Hampton Research and Jena Bioscience. The crystallization drops were pipetted with a nanolitre dispenser (Hydra II, Matrix Technologies) and 400 nl protein solution was mixed with 400 nl reservoir solution. An initial crystallization condition [100 mM HEPES, 10%(w/v) PEG 4000, 5%(v/v) 2-propanol pH 7.5] was optimized in a Cryschem 24-well plate by mixing 1 ml protein solution with 1 ml reservoir solution, varying the pH value and precipitant concentration.
Data collection and analysis
Prior to data collection, crystals were cryoprotected by transferring them stepwise into a stabilizing solution [100 mM HEPES, 12%(w/v) PEG 4000, 5%(v/v) 2-propanol pH 7.3] containing increasing concentrations of glucose [starting at 5%(w/v) and increasing after 2 min incubation at each step to a final concentration of 35%(w/v)]. The crystals were mounted in a nylon loop and flash-frozen in a 100 K nitrogen stream. Diffraction data were collected on beamline 14.2 at BESSY (Berlin) equipped with a MAR 224 CCD detector. The raw diffraction data were integrated with XDS (Kabsch, 2010) and scaled with SCALA (Collaborative Computational Project, Number 4, 1994).
Results and discussion
We were able to express and purify recombinant EDS1 protein in complex with SAG101 derived from A. thaliana. During preparative size-exclusion chromatography, the complex eluted with a retention volume that corresponded to a molecular mass of approximately 110 kDa. Considering the limited accuracy of mass determination by Size-exclusion chromatogram and SDS-PAGE analysis of the EDS1-SAG101 heterodimer. The retention volumes of four standard proteins (ferritin, 440 kDa; catalase, 240 kDa; bovine serum albumin, 66 kDa; RNase, 12 kDa) are shown as references. The major peak at a volume of 75.01 ml corresponds to a calculated mass of approximately 110 kDa and was analyzed by denaturing SDS-PAGE. The indicated fractions were pooled and used for subsequent experiments. gel filtration, this result is broadly consistent with a heterodimer of EDS1 (71.6 kDa) and SAG101 (62.1 kDa) (Fig. 1) . Moreover, SDS-PAGE analysis unambiguously showed that an EDS1-SAG101 heterodimer and not an EDS1 homodimer was purified (Fig. 1) .
Crystallization trials using various commercial screens produced one initial hit for EDS1-SAG101 crystals, the identity of which we verified by mass spectrometry. The optimized crystals grew using 100 mM HEPES, 10%(w/v) PEG 4000, 5%(v/v) 2-propanol, pH 7.3 as a reservoir solution. The crystals were often stuck together and reached final dimensions of 0.1 Â 0.1 Â 0.3 mm within 2 d (Fig. 2) . These crystals diffracted to a maximum resolution of 3.5 Å . A diffraction data set was collected and processed to 3.7 Å resolution ( Fig. 3 ; Table 1 ). Scaling and inspection of systematic absences revealed that the crystals belonged to the orthorhombic space group P2 1 2 1 2 1 , with unit-cell parameters a = 101.8, b = 115.9, c = 122.8 Å . Calculation of the Matthews coefficient produced a single reasonable solution of 2.68 Å 3 Da À1 with one molecule each of EDS1 and SAG101 per unit cell and a corresponding solvent content of 54.14% (Matthews, 1968) .
The overall quality of the data set was low and requires further optimization in order to solve and refine the structure. Although the N-terminal domain of EDS1 and SAG101 is homologous to members of the /-hydrolase fold family the sequence identity does not exceed 30%, with the highest similarity being between the N-terminal EDS1 domain and a lipase from Rhizopus niveus (PDB code 1lgy; Kohno et al., 1996) . Structure determination by the molecularreplacement (MR) method is therefore unlikely to succeed. We have initiated experiments to produce heavy-atom derivatives of the complex for initial phasing. The data presented here provide the first steps towards the ultimate structure determination of this important plant signalling module. Crystals of the EDS1-SAG101 complex grown using PEG 4000 and 2-propanol as precipitants.
Figure 3
Single X-ray diffraction image of an orthorhombic EDS1-SAG101 crystal showing resolution rings. 
